Open Access<p>Validation of Risk of Chemotherapy-Induced Neutropenia: Experience from Oncology Hospital of Nepal</p>
Author(s) -
Binaya Sapkota,
Ronash Shrestha,
Safin Chapagai,
Dip Kiran Shakya,
Prashant Bista
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s243916
Subject(s) - medicine , neutropenia , chemotherapy , febrile neutropenia , cancer , oncology , absolute neutrophil count
The majority of cancer patients undergoing chemotherapy show neutropenic condition which is a common side effect of myelosuppressive chemotherapy diagnosed as the reduced complete blood cell count. Such cancer patients have a higher risk of febrile neutropenia. The present study aimed to validate whether there was a risk of neutropenia in cancer patients receiving chemotherapy at Bhaktapur Cancer Hospital, Nepal.